TechneScan sales to start in Sweden

Radiopharmaceutical developer Mallinckrodt Medical said that it

will begin sales in Sweden of TechneScan Q12, a technetium-based

cardiac imaging agent, following approval of the agent by Sweden's

health authorities. Sweden is the first country in the European

Union to approve TechneScan, and certifications in other European

nations are expected. St. Louis-based Mallinckrodt filed a new

drug application for the product in the U.S. in 1994.